| |NOVEMBER 20257C ONT E NT SWhy Global Pharma Expects CDMOs to Be Ready for Joint InspectionsAshutosh K Sinha, Chief Quality Officer, Neuland LaboratoriesVANTAGE POINTTHOUGHT CENTRALBridging Collaboration Gaps to Boost India's Pharma DiscoveryDr. Sadhna Joglekar, Senior VP & Head - Global Drug Development India, Novartis34AFTERWORD1214How Pharma Authentication Tech Enhances ROI and SafetyAnkit Gupta, President, ASPATRANSFORMING PHARMACEUTICAL INNOVATION THROUGH EXPERT CDMO PARTNERSHIPS
< Page 6 | Page 8 >